Cargando…

Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests

Unlike for advanced liver fibrosis, the practical rules for the early non-invasive diagnosis of cirrhosis in NAFLD remain not well defined. Here, we report the derivation and validation of a stepwise diagnostic algorithm in 1568 patients with NAFLD and liver biopsy coming from four independent cohor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boursier, Jérôme, Roux, Marine, Costentin, Charlotte, Chaigneau, Julien, Fournier-Poizat, Céline, Trylesinski, Aldo, Canivet, Clémence M., Michalak, Sophie, Le Bail, Brigitte, Paradis, Valérie, Bedossa, Pierre, Sturm, Nathalie, de Ledinghen, Victor, Newsome, Philip N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460420/ https://www.ncbi.nlm.nih.gov/pubmed/37633932 http://dx.doi.org/10.1038/s41467-023-40328-4

Ejemplares similares

Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores
por: Sanyal, Arun J., et al.
Publicado: (2023)

Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?
por: Canivet, Clémence M., et al.
Publicado: (2022)

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
por: Newsome, Philip N, et al.
Publicado: (2020)

Spirulina Liquid Extract Protects against Fibrosis Related to Non-Alcoholic Steatohepatitis and Increases Ursodeoxycholic Acid
por: Coué, Marine, et al.
Publicado: (2019)

Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis
por: Schattenberg, Jörn M., et al.
Publicado: (2021)

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease
por: Poynard, Thierry, et al.
Publicado: (2006)

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
por: Ratziu, Vlad, et al.
Publicado: (2006)

HCC risk prediction using biomarkers in non-cirrhotic patients following HCV eradication: Reassuring the patient or the doctor?
por: Costentin, Charlotte E., et al.
Publicado: (2021)

Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD
por: Gonzalez, Concepcion, et al.
Publicado: (2013)

Guidance for Safety and Dosing of Medicines in Patients With Cirrhosis Is Available
por: Weersink, Rianne A., et al.
Publicado: (2019)

Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C
por: Calès, Paul, et al.
Publicado: (2008)

Serum lactate levels in cirrhosis and non-cirrhosis patients with septic shock
por: Tongyoo, Surat, et al.
Publicado: (2022)

Case-finding strategies in non-alcoholic fatty liver disease
por: Boursier, Jerome, et al.
Publicado: (2020)

No association between binge eating disorder and severity of non‐alcoholic fatty liver disease in severely obese patients
por: Canivet, Clémence M, et al.
Publicado: (2020)

Incidental finding of non-alcoholic steatohepatitis-cirrhosis
por: Adrian, Therese, et al.
Publicado: (2022)

IL28B genotype is associated with cirrhosis or transition to cirrhosis in treatment-naive patients with chronic HCV genotype 1 infection: the international observational Gen-C study
por: Mangia, Alessandra, et al.
Publicado: (2016)

Haemorrhagic versus non haemorrhagic ascites in cirrhosis: Their relationship and impact on prognosis of liver cirrhosis
por: Naqvi, Iftikhar Haider, et al.
Publicado: (2020)

Systematic screening for advanced liver fibrosis in patients with coronary artery disease: The CORONASH study
por: Thévenot, Thierry, et al.
Publicado: (2022)

Non-linear magnetic field computations using fast fourier techniques
por: Le Bail, Roland C
Publicado: (1971)

Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19
por: Deckmyn, Olivier, et al.
Publicado: (2022)

Hepatitis C virus prevention and care for drug injectors: the French approach
por: Delile, Jean-Michel, et al.
Publicado: (2018)

Currently Available Non-Balloon Devices
por: Lee, Hang Lak
Publicado: (2018)

Changes in human hepatic metabolism in steatosis and cirrhosis
por: Schofield, Zoe, et al.
Publicado: (2017)

Inflammatory and Non-Inflammatory Mechanisms Controlling Cirrhosis Development
por: Sánchez, Paula Sánchez, et al.
Publicado: (2021)

Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023)

Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression
por: Loyer, Xavier, et al.
Publicado: (2016)

Apple Supplementation Improves Hemodynamic Parameter and Attenuates Atherosclerosis in High-Fat Diet-Fed Apolipoprotein E-Knockout Mice
por: Soleti, Raffaella, et al.
Publicado: (2020)

Carrot Supplementation Improves Blood Pressure and Reduces Aortic Root Lesions in an Atherosclerosis-Prone Genetic Mouse Model
por: Soleti, Raffaella, et al.
Publicado: (2021)

Les effets épigénétiques du cannabis/tétrahydrocannabinol()
por: Costentin, J.
Publicado: (2020)

Personalized management of cirrhosis by non-invasive tests of liver fibrosis
por: Wong, Grace Lai-Hung, et al.
Publicado: (2015)

Evaluation of non-invasive marker of esophageal varices in cirrhosis of liver
por: Kumar, Pardeep, et al.
Publicado: (2020)

Hypoxia Pathways and Cellular Stress Activate Pancreatic Stellate Cells: Development of an Organotypic Culture Model of Thick Slices of Normal Human Pancreas
por: Rebours, Vinciane, et al.
Publicado: (2013)

Current status of liver transplantation for non‐B non‐C liver cirrhosis and hepatocellular carcinoma
por: Nishio, Takahiro, et al.
Publicado: (2022)

Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community‐based cohort
por: Amadou, Coralie, et al.
Publicado: (2022)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
por: Dowman, J K, et al.
Publicado: (2011)

The Role of Imaging in the Detection of Non-COVID-19 Pathologies during the Massive Screening of the First Pandemic Wave
por: Canivet, Perrine, et al.
Publicado: (2022)

Knowledge of liver fibrosis stage among adults with NAFLD/NASH improves adherence to lifestyle changes
por: Carrieri, Patrizia, et al.
Publicado: (2022)

Effect of non-alcoholic beer, diet and exercise on endothelial function, nutrition and quality of life in patients with cirrhosis
por: Macías-Rodríguez, Ricardo U, et al.
Publicado: (2020)

Non-Invasive Diagnostic and Prognostic Evaluation of Liver Cirrhosis and Portal Hypertension
por: Berzigotti, Annalisa, et al.
Publicado: (2011)

Clostridium tertium Bacteremia in a Non-neutropenic Patient with Liver Cirrhosis
por: Wazir, Mohammed, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v9lgtpvg94cvj7konfsf6jl42a